Funded SBIR-STTR projects to Agency firms: some examples Firm/Yr/Agency/$$$ Project Title Consegna Pharma Inc Long Duration, Novel Opioid Medical Countermeasure for Intramuscular Injection 2022 CBD $802,363 Triton Systems Inc Portable Atmospheric Plasma Decontamination 2022 CBD $549,933 ARZEDA Corporation Designer Protein Therapeutics as Medical Countermeasures Against Organophosphate Chemical Warfare Agents: Evaluation and Optimization of Lead Computationally Designed Non-Immunogenic Enzymes 2022 CBD $1,118,433 Program Manager: Larry Pollack Extent of this State's SBIR-STTR participation over life of program Award-related data Awards Phase I Phase II 548 255 Total Award Dollars 1983-current 281684393 Number Awardees 290 Current SBIR-STTR Activity Level Awards (last 5yr) Phase I Phase II 132 63 Award Dollars 76167502 Current Awardees 89 External business factors by State Awardees Publicly Traded 9 M&A Deals 43 VC Funded Firms 52 Total US issued patents 7349 In DOD and NIH particularly, Phase II may be on Phase I awards made three-four years earlier. The comprehensive SBIR tracking system developed and rigorously maintained by the Innovation Development Institute is project-grounded. All related Phase IIs are tracked by relevance to original Phase I i.e. in a single record. As applicable - for example in NIH and some DOD - Phase II awards dollars are recorded incrementally in our offline systems but posted online by total to date. Source: Innovation Development Institute, Swampscott, MA. ©Copyright 1995-2024. All rights reserved. Featured SBIR Firm CytoSorbents Corporation Previously dba - and SBIR Involved - as MedaSorb Technologies Corporation (OTCBB: MSBT), in 2010 the firm was renamed CytoSorbents Corporation (NASDAQ:CTSO): a therapeutic medical ... see more www.cytosorbents.com | (732) 329-8885 Agency Footprint Note: Phase II awards may be incrementally funded. Hence, downturn indicated by this graph is not an error nor a major drop-off of SBIR funding availability. As Phase II awards are made - almost 3/4 of all dollars - steepness of this curve will increase substantially.
